A carregar...

In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae

We evaluated the in vitro potency of cefepime combined with AAI101, a novel extended-spectrum β-lactamase inhibitor, against a population of clinical Escherichia coli and Klebsiella pneumoniae collected from USA hospitals. Of the 223 cefepime non-susceptible isolates, 95% were ceftazidime non-suscep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pathogens
Main Authors: Crandon, Jared L., Nicolau, David P.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4584277/
https://ncbi.nlm.nih.gov/pubmed/26295262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pathogens4030620
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!